Global Ovulation Predictors Market - 2022-2029

Global Ovulation Predictors Market - 2022-2029

Market Overview

The global ovulation predictors market size was valued around US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of YY% during the forecast period (2022-2029).

Ovulation is a biological process of releasing eggs from the ovary every month. Before ovulation, the female body releases luteinizing hormones (LH) in a large amount into the blood, which usually takes place in the middle of the menstrual cycle. Ovulation predictors detect a rise in LH in urine as its concentration increases before the ovulation phase. These tests predict ovulation time and peak fertility. Ovulation predictors are based on LH levels in urine, electrolyte levels in saliva, or the user's basal body temperature. Ovulation predictors provide the comfort of testing at home and help in the detection of luteinizing hormone along with another hormone-like, estrogen.

Market Dynamics

A rise in pregnancy complications drives the market, easy usage and availability of tests, increased pregnancy management and women's health, and technological advancements for reliable and accurate results.

Technological advancement in ovulation predictors is expected to drive market growth.

Fertility-tracking software applications (apps) designed for smartphones and similar devices are increasingly used to time intercourse by women seeking to conceive. Most fertility apps provide forecasts based entirely on user data, such as the latest menstrual period date and cycle duration. However, using a calendar alone to detect the viable window and ovulation has proved ineffective. One study discovered that by utilizing cycle-tracking apps, the probability of correctly identifying a woman's day of ovulation was only 21%. As a result, a way of determining the viable window that combines the precision of an ovulation test with the ease of an app could be useful to women trying to conceive. For instance, The Clearblue Connected Ovulation Test System (Swiss Precision Diagnostics [SPD] GmbH, Geneva, Switzerland) is intended for home use by women. It may reliably forecast the fertile window by tracking spikes in LH and E3G levels that precede ovulation. 21 The test system can link to the user's smartphone through Bluetooth, where the software records the woman's menstrual cycle and uses this information to determine when to perform the pee tests. The urine hormone test reflects one of three degrees of fertility: low when hormone levels are at baseline, high when the monitor detects increasing E3G levels, and peak fertility when the LH surge is detected. Thus, from the above factors, the market is expected to drive in the forecast period.

Restraint:

However, the ovulation test doesn't confirm ovulation; it simply identifies the Luteinizing hormone that precedes ovulation. If the User is on any fertility drugs, the ovulation test does not function properly. The ovulation test does not function for women over 40 or already approaching menopause. Low awareness regarding using Ovulation test kits and the benefits of using devices are the factors the market is expected to get hampered in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic is the most devastating health crisis that humanity has faced in the last century. The lack of viable medicinal options has hampered the fight against the disease. There is currently no clinically licensed vaccine or medicine to treat COVID-19, and the continuous hunt for a novel cure is moving at a pandemic pace. Moreover, because of the work-from-home culture, people mainly stayed at home and had an extended break from work. The respite from their hectic schedules allowed them to spend quality time with their families. Pregnancy rates increased during this time, which boosted the ovulation test kit market. There was no shortage of ovulation test kits because local retailers were open; nonetheless, the low output of ovulation test kits reduced demand in the ovulation test market. Following the post-covid-19 situation, the ovulation kit test market will likely grow rapidly.

Segment Analysis

Urine-Based Ovulation Test Kit segment is estimated to hold the largest market share in ovulation predictors market.

The urine-based ovulation test kit segment accounted for the largest market share in 2021. The segment benefits because these are more accurate than salivary ferning kits, but they're not foolproof. These are very easy to use and can be bought bulk from any supermarket. Urine-Based Test Ovulation Test Kit comes with test strips or sticks. For instance, Clearblue Easy Fertility Monitor, this monitor detects two hormones, LH and estrogen. It allows for detection on more fertile days than paper tests. Therefore, it has increased the demand for the urine-based ovulation test kit. Thus, from the above factors, the market segment is accounted for the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global ovulation predictors market

North America accounted for the largest market share in 2021. Technological advancements in the ovulation predictors, higher adoption of the tests, partnerships and collaborations by the key market players in the region are the factors to drive the market in the forecast period. For instance, a team of Brigham researchers has created a low-cost smartphone gadget that can predict ovulation and aid in family planning using the latest technological advancement. The instrument automatically recognizes fern-like patterns—a hallmark of ovulation—in a saliva sample using microfluidic technology (in which fluids flow through small channels), artificial intelligence (AI), and the pervasiveness of smartphones. The scientists tested the device's effectiveness in the lab using artificial saliva. They validated the results with saliva samples from six patients, achieving higher than 99 percent accuracy in predicting ovulation.

Additionally, through the Real Talk with Conceiving Hood Campaign, actress Jordana Brewster collaborated with Clearblue in April 2021 to raise awareness about the difficulty in conceiving and fertility in women. Therefore, it has increased the adoption of ovulation predictors in the region. Thus, from the above factors, the North America region accounted for the largest market share in the forecast period.

Competitive Landscape

Major key players in the ovulation predictors market are Swiss Precision Diagnostics GmbH, Hilin Life Products, Fairhaven Health LLC, Geratherm Medical AG, Church & Dwight Co. Inc., Prestige Consumer Healthcare, Inc., Piramal Enterprises Ltd., Clearblue, Fertility Focus Limited, and Accuquik.

Swiss Precision Diagnostics GmbH:

Overview:

Swiss Precision Diagnostics (SPD) was formed as a joint venture between Procter & Gamble (P&G) and Alere (now a part of the Abbott group, since October 2017) to create, using its parent companies complementary strengths, one of the world's foremost organizations in consumer diagnostics. Alere (a wholly owned subsidiary of Abbott) is among the world's leading providers of innovative diagnostic products, renowned for their proven reliability in the professional management of women's health and chronic and infectious disease. SPD is currently a leading home pregnancy and fertility/ovulation test supplier. The company has a strong focus on women's reproductive health, and its goals are in the continuing supply of diagnostic products which are accurate, simple and affordable.

Product Portfolio:

Clearblue Advanced Fertility Monitor: Clearblue Advanced Fertility Monitor is one of the most advanced home method proven to increase a woman's chance of conceiving by up to more than 85% in the first two cycles of use. The monitor reliably identifies the days of the cycle when women are most likely to conceive – these are the days before the day of ovulation when an egg is released from the ovary. Having sexual intercourse on the day of ovulation and the days leading up to ovulation provides the best chances of conceiving. The product consists of a handheld monitor and disposable test sticks. The monitor tells the woman when to test and indicates her level of fertility each day. Two hormones are monitored – estrone-3-glucuronide (E3G), a urinary metabolite of estrogen and luteinizing hormone (LH). By monitoring both hormones, the monitor can identify more fertile days than any other home method. It is a unique innovation for couples who are proactively planning pregnancy. It is simple to use, completely natural and 99% accurate in detecting the LH surge.

The global ovulation predictors market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.